Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3389/fimmu.2018.01572

http://scihub22266oqcxt.onion/10.3389/fimmu.2018.01572
suck pdf from google scholar
C6043635!6043635 !30034399
unlimited free pdf from europmc30034399
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=30034399 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid30034399
      Front+Immunol 2018 ; 9 (?): 1572
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Effective Amelioration of Liver Fibrosis Through Lentiviral Vector Carrying Toxoplasma gondii gra15(II) in Murine Model #MMPMID30034399
  • Liu L ; Jin M ; Tao Q ; Yu L ; Du J ; Wang C ; Luo Q ; Xing T ; Xu Y ; Shen J ; Chu D
  • Front Immunol 2018[]; 9 (?): 1572 PMID30034399 show ga
  • Our previous investigations indicated that in vitro polarization of mouse macrophages by Toxoplasma gondii type (II) strain dense granule protein 15 (GRA15 (II) ), one of the genotype-associated effectors of T. gondii, induced the phenotypes of classically activated macrophage (M1). Transfusion of the cells to mice may effectively alleviated hepatic fibrosis caused by schistosomiasis. The purpose of the study was to identify whether liver macrophages can be in vivo driven to M1 macrophages by lentiviral vector (LV) carrying GRA15 (II) gene (LV-gra15 (II) ) and to explore the potential mechanism by which the LV-gra15 (II) -activated liver macrophage (LV-gra15 (II) -M) ameliorates the hepatic fibrosis in schistosomiasis. The mice were treated with LV-gra15 (II) by hydrodynamic injection via the tail vein followed by challenge of Schistosoma japonicum (S. japonicum). Our experiments showed that LV-gra15 (II) was successfully delivered to liver macrophages and GRA15(II) was persistently expressed in the macrophages of mice for at least 2?months. Furthermore, the LV-gra15 (II) infected macrophages were polarized to M1 macrophages in vivo. Consequently, mice with schistosomiasis receiving LV-gra15 (II) injection displayed a remarkable amelioration of liver granuloma formation and collagen deposition in association with downregulated expression of transforming growth factor-beta1, arginase 1 (Arg-1), ?-smooth muscle actin, and an increased expression of matrix metalloproteinase 13 (MMP13). Simultaneously, no negative effects of liver function and vitality of mice were noted. The in vitro experiments indicated that the C-C motif chemokine ligand 2 and nitric oxide level were elevated in LV-gra15 (II) -M cultural supernatants; hepatocyte growth factor expression was enhanced in LV-gra15 (II) -M. In addition, LV-gra15 (II) -M not only secreted MMP13, which greatly degraded type (I) collagen, but also induced murine hepatic stellate cell (HSC) line (JS1) apoptosis in the co-culture system. Taken together, we identified for the first time that LV-gra15 (II) may in vivo drive liver macrophages to M1 macrophage phenotypes, which helps for alteration of the liver fibrotic microenvironment with collagen dissolution, HSC deactivation, apoptosis and hepatocyte protection. Our study gives an insight into the use of gene delivery with parasite-derived immunomodulatory factor as a potential immune cell activating agent to re-equilibrate the other pathogen-induced immune response in some chronic diseases.
  • ?


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box